QuantumScape Reports Q2 Net Loss of $114.7M, Adjusted EBITDA Loss Aligns with Expectations; Full-Year Guidance for Adjusted EBITDA Loss Narrowed to $250M-$270M

Reuters
2025/07/24
QuantumScape Reports <a href="https://laohu8.com/S/QTWO">Q2</a> Net Loss of $114.7M, Adjusted EBITDA Loss Aligns with Expectations; Full-Year Guidance for Adjusted EBITDA Loss Narrowed to $250M-$270M

QuantumScape Corporation has reported its financial results for the second quarter of 2025. The company recorded a GAAP net loss of $114.7 million and an adjusted EBITDA loss of $63.0 million, which was in line with expectations. Capital expenditures for the quarter were $8.3 million, primarily supporting facilities and equipment purchases for higher-volume QSE-5 B1 sample production using the Cobra separator process. QuantumScape has narrowed its full-year guidance for capital expenditures to a range of $45 million to $65 million and its full-year guidance for adjusted EBITDA loss to a range of $250 million to $270 million. The company ended the quarter with $797.5 million in liquidity, extending its cash runway guidance into 2029, a six-month improvement over previous guidance. A significant operational update includes the expansion of QuantumScape's collaboration and licensing arrangement with Volkswagen Group's battery maker, PowerCo. This upgraded deal involves additional payments of up to $131 million over the next two years to support joint commercialization activities, with the first milestones linked to expected payments of more than $10 million already achieved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. QuantumScape Corporation published the original content used to generate this news brief on July 23, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10